KRYS Dividend History & Analysis | Yield
KRYS has a dividend yield of and paid per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| ABBV NYSE AbbVie |
459,822 M | 3.06% | 7.69% |
| NOVO-B CO Novo Nordisk |
205,617 M | 4.66% | 4.18% |
| AMGN NASDAQ Amgen |
240,105 M | 2.74% | 5.43% |
| GILD NASDAQ Gilead Sciences |
185,510 M | 2.56% | 5.44% |
| AZN ST AstraZeneca |
251,374 M | 1.71% | 3.39% |
| HLN NYSE Haleon |
42,217 M | 1.98% | 2.78% |
| ALK-B CO ALK-Abelló |
7,209 M | 0.75% | 1.07% |
| BIOA-B ST BioArctic (publ) |
3,201 M | 0.59% | 1.37% |
| REGN NASDAQ Regeneron Pharmaceuticals |
86,839 M | 0.51% | 0.57% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| NOVO-B CO Novo Nordisk |
205,617 M | 22.43% | 100.0% |
| HLN NYSE Haleon |
42,217 M | 19.13% | 100.0% |
| REGN NASDAQ Regeneron Pharmaceuticals |
86,839 M | 6.96% | 100.0% |
| AMGN NASDAQ Amgen |
240,105 M | 6.69% | 100.0% |
| ABBV NYSE AbbVie |
459,822 M | 5.25% | 100.0% |
| GILD NASDAQ Gilead Sciences |
185,510 M | 2.74% | 100.0% |
| AZN ST AstraZeneca |
251,374 M | 1.57% | 100.0% |
KRYS Dividend History
Dividend Monthly Return EX date, 0 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
KRYS Dividend FAQ
As of September 2026, KRYS's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 351.26.
As of September 2026 KRYS does not pay a dividend.
Over the last 12 months, KRYS has issued dividend payments.
Based on historical data, the forecasted dividends per share for KRYS for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
The next Ex-Dividend date for Krystal Biotech (KRYS) is currently unknown.
The next Ex-Dividend date for Krystal Biotech (KRYS) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
KRYS's average dividend growth rate over the past 5 years is -% per year.
KRYS's 5-Year Yield on Cost is -%. If you bought KRYS's shares at 58.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
KRYS Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
KRYS's % Dividend Yield is considered as unknown.
The Dividend Payout Ratio of KRYS is unknown.
KRYS's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
KRYS Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-09-06 02:05 UTC